Internalisation of Targeted Radiopharmaceuticals: Strategic Imperative or Situational Choice?
- DARPin optimizations to achieve an RLT suitable profile via iterative design – test cycles
- Integrating of these insights for optimized lead selection of the next programs
- How this differs from standard RLT vector development and allows to optimize timelines, costs, resources